109 related articles for article (PubMed ID: 15768446)
1. Trends and influences on use of antidiabetic drugs in England, 1992-2003.
Walley T; Hughes D; Kendall H
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):769-73. PubMed ID: 15768446
[TBL] [Abstract][Full Text] [Related]
2. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
Patel H; Srishanmuganathan J; Car J; Majeed A
J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and costs of diabetes treated with insulin in France.
Detournay B; Raccah D; Cadilhac M; Eschwège E
Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse].
Hauner H; Köster I; von Ferber L
Dtsch Med Wochenschr; 2003 Dec; 128(50):2632-7. PubMed ID: 14673738
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of diabetes in Switzerland: calculation based on drug sales].
Jirovec M; Teuscher A; Bürgi U; Diem P
Schweiz Med Wochenschr; 1993 Nov; 123(47):2247-50. PubMed ID: 8272797
[TBL] [Abstract][Full Text] [Related]
6. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
7. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
Langendam MW; Hooijkaas C; Piepenbrink JF
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
[TBL] [Abstract][Full Text] [Related]
8. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
Rathmann W; Haastert B; Icks A; Giani G
Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
[TBL] [Abstract][Full Text] [Related]
9. Prescription of insulin glargine in primary care practices in Germany.
Rathmann W; Haastert B; Riebel P; Schroeder-Bernhardi D; Kostev K; Huppertz E; Giani G
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):252-6. PubMed ID: 17479442
[TBL] [Abstract][Full Text] [Related]
10. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
11. The use of oral antidiabetic agents in primary care.
Weekes AJ; Thomas MC
Aust Fam Physician; 2007 Jun; 36(6):477-80. PubMed ID: 17565410
[TBL] [Abstract][Full Text] [Related]
12. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
13. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
14. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
[TBL] [Abstract][Full Text] [Related]
15. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
[TBL] [Abstract][Full Text] [Related]
16. [Drug consumption in diabetes mellitus (I). Estimate of the therapeutic profile and the prevalence in the regions of Tarragona (548,900 inhabitants). Grup per a l'Estudi de la Diabetis a Tarragona].
Costa B; Utgés P; Monclús JF; Gomis T; Ciurana MR; Julve P
Med Clin (Barc); 1992 Sep; 99(8):294-9. PubMed ID: 1453822
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
Liberman JN; Berger JE; Lewis M
Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of diabetes mellitus treated with insulin and oral hypoglycemic agents in Denmark.
Nielsen NV; Hemmingsen L
Diabetes Res; 1986 Oct; 3(8):423-5. PubMed ID: 3545623
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
20. Improving glycaemic control in African diabetic patients on insulin: a resource-free approach.
Gill GV; Gebrekidan A; English PJ; Tesfaye S
Trop Doct; 2009 Jan; 39(1):3-5. PubMed ID: 19211409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]